The Attractiveness of Investing In Zomedica Corp. (ZOM) is Growing

Zomedica Corp.’s recent filing unveils that its CEO HEATON LARRY C II acquired Company’s shares for reported $19090.0 on May 26. In the deal valued at $0.19 per share,100,000 shares were bought. As a result of this transaction, HEATON LARRY C II now holds 100,000 shares worth roughly $ 19000.0.

Then, POWERS JOHNNY D bought 100,000 shares, generating $19,340 in total proceeds. Upon buying the shares at $0.19, the Director now owns 1,600,000 shares.

Dawson James initiated its Zomedica Corp. [ZOM] rating to a Buy in a research note published on Friday, January 06, 2023; the price target was $6. PT values the company’s stock at a premium of 96.83 to its Friday closing price.

Price Performance Review of ZOM

On Friday, Zomedica Corp. [AMEX:ZOM] saw its stock jump 2.11% to $0.19. On the same session, the stock had its day’s lowest price of $0.19, but rose to a high of $0.19. Over the last five days, the stock has gained 2.77%. Zomedica Corp. shares have risen nearly 15.89% since the year began. Nevertheless, the stocks have fallen -22.65% over the past one year. While a 52-week high of $0.34 was reached on 01/18/23, a 52-week low of $0.15 was recorded on 01/03/23. SMA at 50 days reached $0.2028, while 200 days put it at $0.2142. A total of 2.8 million shares were traded, compared to the trading of 3.41 million shares in the previous session.

Levels Of Support And Resistance For ZOM Stock

The 24-hour chart illustrates a support level at 0.1854, which if violated will result in even more drops to 0.1818. On the upside, there is a resistance level at 0.1929. A further resistance level may holdings at 0.1968. The Relative Strength Index (RSI) on the 14-day chart is 44.99, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0020, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 55.46%. Stochastics %K at 31.17% indicates the stock is a holding.

How much short interest is there in Zomedica Corp.?

A steep rise in short interest was recorded in Zomedica Corp. stocks on Aug 14, 2023, growing by 1.59 million shares to a total of 68.63 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 67.04 million shares. There was a rise of 2.32%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 7.10% of the overall stock float, the days-to-cover ratio (short ratio) rose to 16.24.

Zomedica Corp. [ZOM] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 48,437,481 shares, or roughly 4.94% of the outstanding ZOM shares. In other words, the investor’s shares have fallen by -179,586 from its previous 13-F filing of 48617067.0. Additionally, BlackRock Fund Advisors increased 12.38% of its stake after which the total value it holdings stand at $2,410,017, while Cambridge Investment Research Adv added 0.01% of its stake to hold $2.36 million in the firm. Over the last quarter, Geode Capital Management LLC purchased 29,530 shares of Zomedica Corp., while SSgA Funds Management, Inc. bought 0 shares. At present, ProShare Advisors LLC is holding 2,949,901 shares valued at $0.62 million. Brown Brothers Harriman & Co. owned 2,285,532 shares of the company at the time of its most recent 13F filing, worth $0.48 million.

According to FactSet, Zomedica Corp.’s share price will average $0.44 in the next year, based on opinions of analysts polled by the firm. This is up nearly 131.58 percent from its previous closing price of $0.19. Analysts expect Zomedica Corp. stock to reach the higher price of $0.44, while the lowest price estimate is $0.44. However, 1 analyst have rated ZOM stock as a Buy in their predictions for 2023.